20th Oct 2014 06:59
LONDON (Alliance News) - ImmuPharma PLC Monday said the French region of Acquitane in the Bordeaux region of the country has awarded its Ureka subsidiary with a EUR400,000 grant.
The funding has been awarded to the company's subsidiary to develop its Urelix technology, which mimics natural peptides having a helical conformation with artificial residues in order to strengthen this conformation and protect it from enzymatic degradation.
ImmuPharma is collaborating with Centre Nationale de la Recherche Scientifique and the Institut Europeen de Chimie et Biologie at Bordeaux University.
"We are honoured to have received the grant from the Bordeaux region, not only for the financial support but also importantly for the validation of our innovative research efforts in conjunction with our research partners. We look forward to announcing more exciting news on our programmes in the coming months," said Robert Zimmer, President and Chief Scientific Officer of Immupharma.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Immupharma